Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.01 USD | -2.87% | +0.25% | -30.62% |
05-29 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
05-28 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.62% | 5.24B | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
+62.67% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.17% | 9.11B | |
-19.53% | 7.32B |
- Stock Market
- Equities
- BBIO Stock
- News BridgeBio Pharma, Inc.
- Insider Sell: BridgeBio Pharma